Atopic dermatitis, asthma, and allergic rhinitis are among the allergic diseases tied to a significantly increased risk for ...

Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ex-Dermira executives.

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar.

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

Attovia Therapeutics has completed an oversubscribed $90 million Series C financing, which the company plans to use along with existing cash and investments to advance its two lead pipeline candidates ...

People allergic to garlic experience immune-related symptoms to allicin and similar compounds. Find guidance on navigating ...

Dubai Derma 2025 at the Dubai World Trade Centre showcases cutting-edge dermatology and laser technologies. Highlights include the CINÉ FIKR DERMA initiative, blending psychiatry and dermatology, and ...

Significant research has documented the impact of atopic dermatitis on mental health. Not only does stress trigger eczema ...

Raj Chovatiya, MD, PhD, MSCI, highlights the long-term effectiveness of lebrikizumab across diverse patients, including those with prior biologic use, positioning it as a potential first-line ...

Using a topical steroid on your face is a common one, but perioral dermatitis can also show up if you’re using thick or oily ...